#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	19758	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1995	979.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1388	1388	C	1083	C	1015	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3607	983.4	0	.	n	.	0	T695C	SNP	695	695	T	1061	1061	C	1108	C,T	1035,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3607	983.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2004	2004	G	1190	G	1104	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3607	983.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2337	2337	C	1154	C,A,T	1060,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3607	983.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2411	2411	A	1122	A	1051	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3607	983.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2963	2963	C	1074	C,A	1011,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2566	folP	855	855	100.0	folP.l15.c4.ctg.1	1408	180.6	1	SNP	p	R229S	1	.	.	685	687	AGC	925	927	AGC	237;235;235	A;G;C	220;219;218	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6640	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3393	195.4	1	SNP	p	S91F	1	.	.	271	273	TTC	615	617	TTC	233;234;237	T;T;C	212;215;217	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6640	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3393	195.4	1	SNP	p	G95N	0	.	.	283	285	GGC	627	629	GGC	233;236;236	G;G;C	212;211;213	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6640	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3393	195.4	1	SNP	p	D95G	1	.	.	283	285	GGC	627	629	GGC	233;236;236	G;G;C	212;211;213	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2006	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1274	154.9	0	.	p	.	0	F184L	NONSYN	550	552	TTC	992	994	TTG	257;257;259	T;T;G	242;240;243	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2006	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1274	154.9	1	SNP	p	G45D	0	.	.	133	135	GGC	575	577	GGC	237;240;244	G;G;C,A	226;226;226,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1078	mtrR_promoter	250	249	99.6	mtrR_promoter.l15.c4.ctg.1	976	109.9	0	.	n	.	0	A197.	DEL	197	197	A	586	586	A	255	A	234	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	222.0	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	265;261;261	G;A,G;C	249;237,1;245	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	222.0	1	SNP	p	R87W	0	.	.	259	261	CGT	538	540	CGT	267;263;265	C,T;G;T	251,1;245;248	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	222.0	1	SNP	p	S87R	1	.	.	259	261	CGT	538	540	CGT	267;263;265	C,T;G;T	251,1;245;248	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	222.0	1	SNP	p	R87I	0	.	.	259	261	CGT	538	540	CGT	267;263;265	C,T;G;T	251,1;245;248	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6438	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	222.0	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	268;268;266	T;C;C	250;249;251	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5160	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2584	198.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1523	1525	GGC	248;245;241	G;G;C,T,G	221;217;213,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1227	1229	GCA	251;251;259	G,A;C;A	227,1;226;236	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1230	1232	ATC	257;256;254	A;T;C,T	235;235;229,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1242	1244	GTG	267;268;266	G;T;G	244;239;238	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1242	1244	GTG	267;268;266	G;T;G	244;239;238	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1746	1748	ACC	274;272;270	A,C;C;C	249,1;251;253	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1800	1802	GCG	247;244;247	G;C,T;G	220;196,1;211	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1800	1802	GCG	247;244;247	G;C,T;G	220;196,1;211	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1923	1925	AGC	239;240;238	A;G;C	218;216;215	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1932	1934	GGC	233;232;236	G;G;C	207;207;210	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4980	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2339	211.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1950	1952	CCG	215;220;221	C,G;CG,CGG;G	156,4;153,1;166	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7176	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3254	220.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1734	1736	CCG	255;255;258	C;C;G	234;239;232	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2764	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1660	165.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	498	498	C	192	C	173	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	T18M	NONSYN	52	54	ACG	403	405	ATG	264;263;263	A;T;G	243;238;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	T26A	NONSYN	76	78	ACC	427	429	GCC	273;273;275	G;C;C	251;249;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	463	465	GAA	272;273;273	G;A;A	252;255;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	K41N	NONSYN	121	123	AAA	472	474	AAC	268;267;271	A;A;C	250;249;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	751	753	GAT	314;315;316	G;A;T	290;292;290	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	874	876	TCA	309;315;317	T;C;A	288;295;298	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	D212N	NONSYN	634	636	GAT	985	987	AAT	305;303;302	A;A;T	292;292;287	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	S217N	NONSYN	649	651	AGT	1000	1002	AAT	303;301;302	A;A;T	292;289;288	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1003	1005	GTC	303;304;304	G,C;T;C	286,1;285;293	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1015	1017	TCT	313;312;311	T;C;T	299;299;300	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	W257L	NONSYN	769	771	TGG	1120	1122	TTG	324;321;321	T;T;G	301;299;296	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	A296V	NONSYN	886	888	GCA	1237	1239	GTA	305;302;305	G;T;A	285;282;285	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	A323V	NONSYN	967	969	GCC	1318	1320	GTC	234;230;229	G;T;C	216;211;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1333	1335	GCA	240;239;239	G;C;A	219;223;222	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3448	porB1b	1047	1047	97.8	porB1b.l15.c4.ctg.1	1534	223.5	0	.	p	.	0	I335T	NONSYN	1003	1005	ATC	1354	1356	ACC	238;231;227	A;C;C	217;214;211	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	14500	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4975	290.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1492	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1094	135.8	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	339;340;334	A;T;G	316;316;309	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
